DK1470226T3 - Kontrol af genekspression ved anvendelse af et oligonukleotid og regulatorisk peptid - Google Patents

Kontrol af genekspression ved anvendelse af et oligonukleotid og regulatorisk peptid

Info

Publication number
DK1470226T3
DK1470226T3 DK02801387T DK02801387T DK1470226T3 DK 1470226 T3 DK1470226 T3 DK 1470226T3 DK 02801387 T DK02801387 T DK 02801387T DK 02801387 T DK02801387 T DK 02801387T DK 1470226 T3 DK1470226 T3 DK 1470226T3
Authority
DK
Denmark
Prior art keywords
gene expression
molecule
nucleic acid
methods
modulating
Prior art date
Application number
DK02801387T
Other languages
Danish (da)
English (en)
Inventor
Satu Vainikka
Stephen Hart
Simak Ali
Boris Tumi Pufong
Andrew Christopher Geor Porter
Laki Buluwela
John David Jenkinson
Patrick Kanda
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9923615&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1470226(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Application granted granted Critical
Publication of DK1470226T3 publication Critical patent/DK1470226T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01048—Histone acetyltransferase (2.3.1.48)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02801387T 2001-10-11 2002-10-11 Kontrol af genekspression ved anvendelse af et oligonukleotid og regulatorisk peptid DK1470226T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0124391.4A GB0124391D0 (en) 2001-10-11 2001-10-11 Control of gene expression
PCT/GB2002/004633 WO2003033701A1 (en) 2001-10-11 2002-10-11 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide

Publications (1)

Publication Number Publication Date
DK1470226T3 true DK1470226T3 (da) 2007-12-10

Family

ID=9923615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02801387T DK1470226T3 (da) 2001-10-11 2002-10-11 Kontrol af genekspression ved anvendelse af et oligonukleotid og regulatorisk peptid

Country Status (11)

Country Link
EP (1) EP1470226B1 (es)
AT (1) ATE368737T1 (es)
AU (1) AU2002334142B2 (es)
CA (1) CA2474216C (es)
CY (1) CY1107754T1 (es)
DE (1) DE60221572T2 (es)
DK (1) DK1470226T3 (es)
ES (1) ES2291536T3 (es)
GB (2) GB0124391D0 (es)
PT (1) PT1470226E (es)
WO (1) WO2003033701A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508052A1 (en) * 2002-12-05 2004-06-17 Imperial College Innovations Limited Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
NL1027311C2 (nl) * 2004-10-21 2006-05-01 Synvolux Ip B V Vehikel voor transport van een DNA-modificerend enzym naar een genoom.
NL1027479C2 (nl) * 2004-10-21 2006-05-01 Synvolux Ip B V Bescherming van biologisch actieve moleculen met behulp van amphifielen.
US8883507B2 (en) 2005-10-18 2014-11-11 The Regents Of The University Of Colorado Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
WO2009139930A2 (en) 2008-05-16 2009-11-19 Taiga Biotechnologies, Inc. Antibodies and processes for preparing the same
DK2966084T3 (en) 2008-08-28 2018-08-06 Taiga Biotechnologies Inc MODULATORS OF MYC, PROCEDURES FOR USING SAME AND PROCEDURES FOR IDENTIFYING SUBSTANCES MODULATING MYC
WO2011154542A1 (en) * 2010-06-11 2011-12-15 Artisense Pharma Gmbh Method for selective oligonucleotide modification
CA3133302A1 (en) 2012-07-20 2014-01-23 Taiga Biotechnologies, Inc. Enhanced reconstitution and autoreconstitution of the hematopoietic compartment comprising a myc polypeptide
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer
CA3045017A1 (en) 2016-12-02 2018-06-07 Taiga Biotechnologies, Inc. Nanoparticle formulations
MX2019015188A (es) 2017-06-15 2020-08-03 Univ California Inserciones de adn no virales orientadas.
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
MX2020004325A (es) 2017-10-27 2020-11-09 Univ California Reemplazo dirigido de receptores de células t endógenos.
IL311570A (en) 2021-10-14 2024-05-01 Arsenal Biosciences Inc Immune cells with common expression chain and logic gate systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
AU1395999A (en) * 1997-11-10 1999-05-31 Salk Institute For Biological Studies, The Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
JP2002519688A (ja) * 1998-07-02 2002-07-02 インダストリアル リサーチ リミテッド コリオリ式流体流量計
GB9915126D0 (en) * 1999-06-30 1999-09-01 Imp College Innovations Ltd Control of gene expression
CA2316036A1 (en) * 1999-08-27 2001-02-27 Keqiang Wu Repressing gene expression in plants
WO2001059094A2 (en) * 2000-02-11 2001-08-16 The Salk Institute For Biological Studies Method of regulating transcription in a cell by altering remodeling of cromatin

Also Published As

Publication number Publication date
ATE368737T1 (de) 2007-08-15
ES2291536T3 (es) 2008-03-01
DE60221572D1 (de) 2007-09-13
GB2382581A (en) 2003-06-04
EP1470226B1 (en) 2007-08-01
CA2474216C (en) 2012-03-13
PT1470226E (pt) 2007-11-02
WO2003033701A1 (en) 2003-04-24
GB0223605D0 (en) 2002-11-20
AU2002334142B2 (en) 2007-12-13
GB0124391D0 (en) 2001-11-28
EP1470226A1 (en) 2004-10-27
CA2474216A1 (en) 2003-04-24
CY1107754T1 (el) 2013-04-18
DE60221572T2 (de) 2008-04-17

Similar Documents

Publication Publication Date Title
CY1107754T1 (el) Ελεγχος γονιδιακης εκφρασης χρησιμοποιωντας συμπλεγμα ολιγονουκλεοτιδιου και ρυθμιστικου πεπτιδιου
Nair et al. Chromatin dynamics in genome stability: roles in suppressing endogenous DNA damage and facilitating DNA repair
Gill Something about SUMO inhibits transcription
NO20025402L (no) Modifiserte ES-celler og ES-cellespesifikke gener
EP1229134A3 (en) Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
DK0941318T3 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
WO2004011624A3 (en) Double stranded rna structures and constructs, and methods for generating and using the same
ATE174599T1 (de) Bindungskompetente oligomere, die 2',5'-bindungen enthalten
WO1998027201A3 (de) Gene codierend für aminosäure-deacetylasen mit spezifität für n-acetyl-l-phosphinothricin, ihre isolierung und verwendung
WO2002012325A3 (en) Suppressor gene
GB2367555A (en) Control of gene expression
WO2000053776A3 (en) Human kallikrein-like genes
ATE280947T1 (de) Funktionelle fragmente des hiv-1 vpr proteins and eine methode zu seiner anwendung
WO2002022662A3 (en) Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor
WO2004050885A3 (en) Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
DE60214867D1 (en) Histonedeacetylase 9
Ehrensberger et al. Reprogramming chromatin
FR2809414B1 (fr) Acide nucleique regulateur du gene abc1, molecules modulant son activite et applications therapeutiques
HUP0203724A2 (hu) Humán heparanázzal rokon polipeptidek és nukleinsavak
WO2004047758A3 (en) Methods of therapy and diagnosis using targeting of cells that express p2y10
WO2003044170A3 (en) Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
WO2004108898A3 (en) Transfection agents
NO20023914D0 (no) Preparater for anvendelse ved regulering av Parkin- genaktiviteten
WO2003010308A3 (en) Control of gene expression
Dai et al. Genetically-encoded degraders as versatile modulators of intracellular therapeutic targets